Squarepoint
IMVT icon

Squarepoint’s Immunovant IMVT Stock Holding History

Squarepoint’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-84,919
Closed -$1.36M – 4642
2025
Q2 		$1.36M Buy
84,919
+74,494
+715% +$1.13M ﹤0.01% 2393
2025
Q1 		$178K Buy
+10,425
New +$218K ﹤0.01% 4055
2024
Q3 		– Sell
-49,288
Closed -$1.3M – 4372
2024
Q2 		$1.3M Buy
49,288
+2,615
+6% +$74.4K ﹤0.01% 2367
2024
Q1 		$1.51M Buy
+46,673
New +$1.7M ﹤0.01% 2292
2023
Q4 		– Sell
-14,587
Closed -$560K – 4237
2023
Q3 		$560K Buy
+14,587
New +$330K ﹤0.01% 2713
2023
Q2 		– Sell
-93,895
Closed -$1.46M – 3769
2023
Q1 		$1.46M Buy
93,895
+58,943
+169% +$1.02M 0.01% 1634
2022
Q4 		$620K Buy
+34,952
New +$440K ﹤0.01% 2147
2022
Q2 		– Sell
-28,037
Closed -$154K – 3101
2022
Q1 		$154K Sell
28,037
-39,879
-59% -$248K ﹤0.01% 2540
2021
Q4 		$579K Sell
67,916
-10,364
-13% -$85.6K ﹤0.01% 2049
2021
Q3 		$680K Buy
78,280
+42,874
+121% +$387K ﹤0.01% 1790
2021
Q2 		$374K Sell
35,406
-11,439
-24% -$160K ﹤0.01% 2360
2021
Q1 		$751K Buy
46,845
+24,458
+109% +$645K ﹤0.01% 1733
2020
Q4 		$1.03M Buy
22,387
+4,777
+27% +$221K 0.01% 1309
2020
Q3 		$620K Buy
+17,610
New +$530K 0.01% 1267

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Squarepoint's IMVT Position: Q3 2025 in Review

Squarepoint sold out of Immunovant (IMVT) in Q3 2025, closing a stake of 84,919 shares — an estimated $1.36M sold.

Squarepoint first reported a position in IMVT in Q3 2020 and held it in 14 quarters. The position peaked at $1.51M in Q1 2024. 186 funds tracked by Wall St. Rank hold IMVT as of Q3 2025.

  • Squarepoint reported no remaining Immunovant position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 84,919 Immunovant shares in Q3 2025, an estimated $1.36M.
  • Squarepoint first reported a position in Immunovant in Q3 2020 and held it in 14 quarters.
  • Squarepoint's Immunovant position peaked at $1.51M in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.